5-1294027-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198253.3(TERT):c.859G>A(p.Gly287Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000751 in 1,597,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_198253.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERT | NM_198253.3 | c.859G>A | p.Gly287Ser | missense_variant | 2/16 | ENST00000310581.10 | NP_937983.2 | |
TERT | NM_001193376.3 | c.859G>A | p.Gly287Ser | missense_variant | 2/15 | NP_001180305.1 | ||
TERT | NR_149162.3 | n.938G>A | non_coding_transcript_exon_variant | 2/13 | ||||
TERT | NR_149163.3 | n.938G>A | non_coding_transcript_exon_variant | 2/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TERT | ENST00000310581.10 | c.859G>A | p.Gly287Ser | missense_variant | 2/16 | 1 | NM_198253.3 | ENSP00000309572.5 | ||
TERT | ENST00000334602.10 | c.859G>A | p.Gly287Ser | missense_variant | 2/15 | 1 | ENSP00000334346.6 | |||
TERT | ENST00000460137.6 | n.859G>A | non_coding_transcript_exon_variant | 2/13 | 1 | ENSP00000425003.1 | ||||
TERT | ENST00000656021.1 | n.859G>A | non_coding_transcript_exon_variant | 2/17 | ENSP00000499759.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.00000911 AC: 2AN: 219430Hom.: 0 AF XY: 0.00000835 AC XY: 1AN XY: 119742
GnomAD4 exome AF: 0.00000554 AC: 8AN: 1445240Hom.: 0 Cov.: 34 AF XY: 0.00000418 AC XY: 3AN XY: 718140
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74360
ClinVar
Submissions by phenotype
Acute myeloid leukemia;C3151443:Dyskeratosis congenita, autosomal dominant 2;C3553617:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1;C3554574:Melanoma, cutaneous malignant, susceptibility to, 9 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 07, 2024 | - - |
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 02, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 287 of the TERT protein (p.Gly287Ser). This variant is present in population databases (rs746095609, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with TERT-related conditions. ClinVar contains an entry for this variant (Variation ID: 579760). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TERT protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 21, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at